Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck Cancer

Phase 2 Completed 27 enrolled Washington University School of Medicine

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether Amifostine provides additional protection of salivary gland function over that achieved with IMRT alone.

Timeline

Start: 2001-10
Primary completion: —
Completion: 2007-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	amifostine	Unknown	—	—

Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck Cancer

Summary

Timeline

Drugs

Indications